U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284927) titled 'Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies' on Dec. 03.
Brief Summary: This clinical trial is designed as a single-arm, open-label, single-center, investigator-initiated, early-phase study. Its primary objective is to evaluate the safety of LV009 Injection in subjects with relapsed/refractory CD19-positive hematolymphoid malignancies.
Study Start Date: Dec. 03
Study Type: INTERVENTIONAL
Condition:
Non-Hodgkin Lymphoma
Acute Lymphoblastic Leukemia
Intervention:
BIOLOGICAL: LV009 Injection
Eligible subjects who pass the screening process after providing signed informed consent w...